中华医学杂志（英文版）2018，Vol.131Issue(23)：2776-2784,9.DOI:10.4103/0366‑6999.246067
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis:A Subgroup Analysis of the Phase 3 TOWER Study
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis:A Subgroup Analysis of the Phase 3 TOWER Study
Wei Qiu 1Yi-Ning Huang 2Dong Zhou 3Wei-Ping Wu 4Bao-Jun Wang 5Ji-Mei Li 6Xing-Hu Zhang 7Yan Cheng 8Hai-Feng Li 9Ling Li 10Chuan-Zhen Lu 11De-Hui Huang 12Xu Zhang 5Bi-Tao Bu 13Wan-Li Dong 14Dong-Sheng Fan 15Xue-Qiang Hu 16Xian-Hao Xu 1Shi-Fang Hou 2Mei-Ni Zhang 17Tao Jin 17Hui-Qing Dong 18Hua Peng 19Chao-Dong Zhang 20Gang Zhao21
作者信息
- 1. Department of Neurology, The Third Affiliated Hospital of Sun Yat?Sen University, Guangzhou, Guangdong 510000, China
- 2. Qilu Hospital of Shandong University, Jinan, Shandong 250012, China
- 3. 0Department of Neurology, Peking University First Hospital, Beijing 100034, China
- 4. Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
- 5. Department of Neurology, Chinese People's Liberation Army General Hospital, Beijing 100853, China
- 6. Department of Neurology, Baotou Central Hospital, Baotou, Inner Mongolia 014040, China
- 7. Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100000, China
- 8. Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, Beijing 100050, China
- 9. Department of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, China
- 10. Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China
- 11. Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China
- 12. Department of Neurology, Hua Shan Hospital of the Shanghai Fudan University Medical College, Shanghai 200040, China
- 13. Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China
- 14. Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China
- 15. Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, China
- 16. Department of Neurology, Beijing Hospital, National Center of Gerontology, Beijing 100083, China
- 17. Department of Neurology, Beijing Hospital, Beijing 100730, China
- 18. Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China
- 19. Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin 130012, China
- 20. Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
- 21. Department of Neurology, Shanghai Chang Zheng Hospital, Shanghai 200003, China
- 折叠
摘要
关键词
Chinese Patients/Efficacy/Phase 3/Relapsing Multiple Sclerosis/Safety/Teriflunomide/TOWERKey words
Chinese Patients/Efficacy/Phase 3/Relapsing Multiple Sclerosis/Safety/Teriflunomide/TOWER引用本文复制引用
Wei Qiu,Yi-Ning Huang,Dong Zhou,Wei-Ping Wu,Bao-Jun Wang,Ji-Mei Li,Xing-Hu Zhang,Yan Cheng,Hai-Feng Li,Ling Li,Chuan-Zhen Lu,De-Hui Huang,Xu Zhang,Bi-Tao Bu,Wan-Li Dong,Dong-Sheng Fan,Xue-Qiang Hu,Xian-Hao Xu,Shi-Fang Hou,Mei-Ni Zhang,Tao Jin,Hui-Qing Dong,Hua Peng,Chao-Dong Zhang,Gang Zhao..Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis:A Subgroup Analysis of the Phase 3 TOWER Study[J].中华医学杂志（英文版）,2018,131(23):2776-2784,9.
